JP2017510542A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017510542A5 JP2017510542A5 JP2016533700A JP2016533700A JP2017510542A5 JP 2017510542 A5 JP2017510542 A5 JP 2017510542A5 JP 2016533700 A JP2016533700 A JP 2016533700A JP 2016533700 A JP2016533700 A JP 2016533700A JP 2017510542 A5 JP2017510542 A5 JP 2017510542A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- gene editing
- gene
- editing protein
- synthetic rna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461934397P | 2014-01-31 | 2014-01-31 | |
| US61/934,397 | 2014-01-31 | ||
| US201462038608P | 2014-08-18 | 2014-08-18 | |
| US62/038,608 | 2014-08-18 | ||
| US201462069667P | 2014-10-28 | 2014-10-28 | |
| US62/069,667 | 2014-10-28 | ||
| PCT/US2015/013949 WO2015117021A1 (en) | 2014-01-31 | 2015-01-30 | Methods and products for nucleic acid production and delivery |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020128881A Division JP7235702B2 (ja) | 2014-01-31 | 2020-07-30 | 核酸生成及び送達のための方法及び製品 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017510542A JP2017510542A (ja) | 2017-04-13 |
| JP2017510542A5 true JP2017510542A5 (enExample) | 2018-03-08 |
Family
ID=53757787
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016533700A Pending JP2017510542A (ja) | 2014-01-31 | 2015-01-30 | 核酸生成及び送達のための方法及び製品 |
| JP2020128881A Active JP7235702B2 (ja) | 2014-01-31 | 2020-07-30 | 核酸生成及び送達のための方法及び製品 |
| JP2023026873A Pending JP2023075165A (ja) | 2014-01-31 | 2023-02-24 | 核酸生成及び送達のための方法及び製品 |
| JP2024151104A Pending JP2025003953A (ja) | 2014-01-31 | 2024-09-03 | 核酸生成及び送達のための方法及び製品 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020128881A Active JP7235702B2 (ja) | 2014-01-31 | 2020-07-30 | 核酸生成及び送達のための方法及び製品 |
| JP2023026873A Pending JP2023075165A (ja) | 2014-01-31 | 2023-02-24 | 核酸生成及び送達のための方法及び製品 |
| JP2024151104A Pending JP2025003953A (ja) | 2014-01-31 | 2024-09-03 | 核酸生成及び送達のための方法及び製品 |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US9770489B2 (enExample) |
| EP (3) | EP3690056B1 (enExample) |
| JP (4) | JP2017510542A (enExample) |
| KR (3) | KR20240162163A (enExample) |
| CN (1) | CN105940110A (enExample) |
| AU (3) | AU2015210769B2 (enExample) |
| BR (1) | BR112016017736A2 (enExample) |
| CA (1) | CA2937036A1 (enExample) |
| DK (1) | DK3690056T5 (enExample) |
| ES (2) | ES2787198T3 (enExample) |
| FI (1) | FI3690056T3 (enExample) |
| MX (2) | MX372651B (enExample) |
| RU (2) | RU2714404C2 (enExample) |
| WO (1) | WO2015117021A1 (enExample) |
Families Citing this family (83)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013066438A2 (en) | 2011-07-22 | 2013-05-10 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
| US20150044192A1 (en) | 2013-08-09 | 2015-02-12 | President And Fellows Of Harvard College | Methods for identifying a target site of a cas9 nuclease |
| US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
| US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| US9388430B2 (en) | 2013-09-06 | 2016-07-12 | President And Fellows Of Harvard College | Cas9-recombinase fusion proteins and uses thereof |
| US20150166984A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting alpha-antitrypsin point mutations |
| CN105940110A (zh) | 2014-01-31 | 2016-09-14 | 菲克特生物科学股份有限公司 | 用于核酸产生和递送的方法和产品 |
| WO2016022363A2 (en) | 2014-07-30 | 2016-02-11 | President And Fellows Of Harvard College | Cas9 proteins including ligand-dependent inteins |
| AU2015338923B2 (en) | 2014-11-02 | 2021-10-21 | Arcturus Therapeutics, Inc. | Messenger UNA molecules and uses thereof |
| WO2016131052A1 (en) * | 2015-02-13 | 2016-08-18 | Factor Bioscience Inc. | Nucleic acid products and methods of administration thereof |
| SG10202104041PA (en) | 2015-10-23 | 2021-06-29 | Harvard College | Nucleobase editors and uses thereof |
| US11459560B2 (en) | 2015-11-23 | 2022-10-04 | The Regents Of The University Of Colorado | Methods and compositions for reprogramming cells |
| SI3377637T1 (sl) * | 2016-04-08 | 2020-08-31 | Krystal Biotech, Inc. | Sestavki za uporabo pri postopkih za zdravljenje ran, motenj in bolezni kože |
| EP3241905A1 (en) * | 2016-05-06 | 2017-11-08 | Miltenyi Biotec GmbH | Method for introducing nucleic acids into a cell |
| WO2017197141A2 (en) * | 2016-05-13 | 2017-11-16 | Sangamo Therapeutics, Inc. | Targeted treatment of androgenic alopecia |
| WO2018003952A1 (ja) * | 2016-06-29 | 2018-01-04 | センジュ ユーエスエー、インコーポレイテッド | 経皮薬物送達システムおよびその使用方法 |
| KR20250103795A (ko) | 2016-08-03 | 2025-07-07 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 아데노신 핵염기 편집제 및 그의 용도 |
| US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
| IL308824A (en) | 2016-08-17 | 2024-01-01 | Factor Bioscience Inc | Nucleic acid products and methods of administration thereof |
| WO2018039438A1 (en) | 2016-08-24 | 2018-03-01 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| SG11201903089RA (en) | 2016-10-14 | 2019-05-30 | Harvard College | Aav delivery of nucleobase editors |
| CN110023325B (zh) * | 2016-10-14 | 2023-07-04 | 尼优美特里克斯医疗有限公司 | 具有提高的生物活性和降低的对嗜中性粒细胞弹性蛋白酶降解易感性的来源于纤连蛋白的肽 |
| EP3808380A1 (en) * | 2016-12-08 | 2021-04-21 | CureVac AG | Rna for treatment or prophylaxis of a liver disease |
| WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
| US11898179B2 (en) | 2017-03-09 | 2024-02-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
| EP3592381A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Cancer vaccine |
| WO2018165629A1 (en) | 2017-03-10 | 2018-09-13 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
| WO2018176009A1 (en) | 2017-03-23 | 2018-09-27 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable dna binding proteins |
| EP3600379B1 (en) | 2017-03-31 | 2022-12-21 | Accanis Biotech F&E GmbH & Co KG | Prevention and treatment of non-melanoma skin cancer (nmsc) |
| CN107400635A (zh) * | 2017-04-27 | 2017-11-28 | 广州弘宝元生物科技有限公司 | 导入α‑MSH多肽的粘红酵母重组菌株及其制备方法和应用 |
| WO2018209320A1 (en) | 2017-05-12 | 2018-11-15 | President And Fellows Of Harvard College | Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation |
| SG11201912179SA (en) | 2017-06-15 | 2020-01-30 | Univ California | Targeted non-viral dna insertions |
| CN111801345A (zh) | 2017-07-28 | 2020-10-20 | 哈佛大学的校长及成员们 | 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物 |
| EP3437650A1 (en) * | 2017-07-31 | 2019-02-06 | Accanis Biotech F&E GmbH & Co KG | Treatment of local skin hypotrophy conditions |
| BR102017016440A2 (pt) | 2017-07-31 | 2019-03-19 | Universidade Federal Do Rio Grande Do Sul | Composição para terapia gênica do sistema nervoso central, processo de obtenção e uso da mesma |
| EP3676376B1 (en) | 2017-08-30 | 2025-01-15 | President and Fellows of Harvard College | High efficiency base editors comprising gam |
| AU2018328119B2 (en) | 2017-09-05 | 2025-07-10 | Azitra Inc | Methods and compositions for treating inflammatory skin disease with recombinant microorganisms |
| WO2019075263A2 (en) * | 2017-10-11 | 2019-04-18 | Illustris Pharmaceuticals, Inc. | METHODS AND COMPOSITIONS WITH TOPICAL ADMINISTRATION |
| US11795443B2 (en) | 2017-10-16 | 2023-10-24 | The Broad Institute, Inc. | Uses of adenosine base editors |
| WO2019084552A1 (en) | 2017-10-27 | 2019-05-02 | The Regents Of The University Of California | TARGETED REPLACEMENT OF ENDOGENIC T CELL RECEPTORS |
| WO2019118949A1 (en) | 2017-12-15 | 2019-06-20 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| EP3543351B1 (en) | 2018-03-19 | 2022-08-10 | Ricoh Company, Ltd. | Nucleic acid sample-contained container, method for producing nucleic acid sample-contained container, and nucleic acid sample |
| AU2019243155A1 (en) * | 2018-03-27 | 2020-10-15 | Factor Bioscience Inc. | Nucleic acid-based therapeutics |
| WO2019195714A1 (en) * | 2018-04-05 | 2019-10-10 | Azitra Inc | Methods and compositions for treating skin disease with recombinant microorganisms |
| WO2019200163A1 (en) | 2018-04-12 | 2019-10-17 | Krystal Biotech, Inc. | Compositions and methods for the treatment of autosomal recessive congenital ichthyosis |
| CN112041434A (zh) * | 2018-04-27 | 2020-12-04 | 克里斯托生物技术股份有限公司 | 用于美容性应用的编码一种或多种美容蛋白的重组核酸 |
| US12157760B2 (en) | 2018-05-23 | 2024-12-03 | The Broad Institute, Inc. | Base editors and uses thereof |
| EP3820495A4 (en) | 2018-07-09 | 2022-07-20 | The Broad Institute Inc. | RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES |
| EP3841204A4 (en) | 2018-08-23 | 2022-05-18 | Sangamo Therapeutics, Inc. | CHANGED TARGET SPECIFIC BASE EDITORS |
| CA3112627A1 (en) | 2018-09-24 | 2020-04-02 | Krystal Biotech, Inc. | Compositions and methods for the treatment of netherton syndrome |
| WO2020069018A1 (en) * | 2018-09-26 | 2020-04-02 | Krystal Biotech, Inc. | Compositions and methods for the treatment of skin diseases |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| US12174174B2 (en) * | 2018-10-31 | 2024-12-24 | National Cancer Center | Composition comprising material for regulating OCT4 modification to repress stemness |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| MX2021008832A (es) | 2019-02-08 | 2021-09-08 | Krystal Biotech Inc | Composiciones y metodos para la administracion de polipeptidos cftr. |
| US20220142896A1 (en) * | 2019-03-01 | 2022-05-12 | Flagship Pioneering Innovations Vi, Llc | Polyribonucleotides and cosmetic uses thereof |
| EP3942043A2 (en) | 2019-03-19 | 2022-01-26 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| WO2020214842A1 (en) | 2019-04-17 | 2020-10-22 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| JP7699552B2 (ja) | 2019-07-03 | 2025-06-27 | ファクター バイオサイエンス インコーポレイテッド | カチオン性脂質及びその使用 |
| US20210000910A1 (en) | 2019-07-03 | 2021-01-07 | Jysk Skin Solutions Pte Ltd | Topical compositions |
| US10501404B1 (en) | 2019-07-30 | 2019-12-10 | Factor Bioscience Inc. | Cationic lipids and transfection methods |
| CN110467667B (zh) * | 2019-09-03 | 2020-11-24 | 中国科学院理化技术研究所 | 一种抗肿瘤活性肽及其应用 |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| BR112022022603A2 (pt) | 2020-05-08 | 2023-01-17 | Broad Inst Inc | Métodos e composições para edição simultânea de ambas as fitas de sequência alvo de nucleotídeos de fita dupla |
| CN114717229B (zh) * | 2021-01-05 | 2024-09-10 | 麦塞拿治疗(香港)有限公司 | 治疗性mRNA的无细胞和无载体体外RNA转录方法和核酸分子 |
| AU2022246917A1 (en) | 2021-04-02 | 2023-10-12 | Krystal Biotech, Inc. | Viral vectors for cancer therapy |
| CN113603739B (zh) * | 2021-08-27 | 2024-08-23 | 上海兆维科技发展有限公司 | 一种加帽类似物及其应用 |
| JP2024533316A (ja) * | 2021-09-08 | 2024-09-12 | フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー | ゲノムを調節するための方法及び組成物 |
| IL311570A (en) | 2021-10-14 | 2024-05-01 | Arsenal Biosciences Inc | Immune cells with common expression chain and logic gate systems |
| CN114150022B (zh) * | 2021-12-06 | 2023-08-22 | 中国科学院精密测量科学与技术创新研究院 | 一种基于植物微纳结构的生化分子细胞递送方法及应用 |
| JP7271026B1 (ja) * | 2021-12-28 | 2023-05-11 | 株式会社Hyperion Drug Discovery | 遺伝子導入細胞の免疫応答を回避させるための剤 |
| US12551551B2 (en) * | 2022-01-05 | 2026-02-17 | Helix Nanotechnologies Inc | Compositions comprising α-factor prepro sequence and uses thereof |
| CN114480365B (zh) * | 2022-01-18 | 2024-05-28 | 南昌大学 | 一种高分子-酶-无机杂化纳米花及其制备方法与其在降解食用油中真菌毒素的应用 |
| WO2023191016A1 (ja) * | 2022-03-30 | 2023-10-05 | ヤマサ醤油株式会社 | フィブリリン産生促進剤、化粧料組成物又は皮膚外用剤、経口投与剤、及びエラスチン線維産生促進剤 |
| US12083204B2 (en) | 2022-06-02 | 2024-09-10 | L'oreal | Topical composition for homeostatic delivery of nitric oxide and uses thereof |
| TWI860814B (zh) | 2022-08-10 | 2024-11-01 | 南韓商韓華思路信股份有限公司 | 異氰酸酯組成物的製備方法及異氰酸酯組成物 |
| EP4656177A4 (en) * | 2023-01-27 | 2026-05-13 | Sungkwang Medical Found | Composition containing Nidogene to improve skin condition, treat skin lesions, or maintain stem cell function |
| CN116474120A (zh) * | 2023-04-03 | 2023-07-25 | 臻赫医药(杭州)有限公司 | 重编程因子抗衰老mRNA组合物、制备方法及应用 |
| WO2024214050A1 (en) * | 2023-04-11 | 2024-10-17 | Eliksa Therapeutics, Inc. | Methods of increasing therapeutic protein levels and/or improving cellular function with amniotic fluid compositions |
| WO2025024500A1 (en) * | 2023-07-25 | 2025-01-30 | Passport Technologies, Inc. | Methods and systems for transdermal immunotherapy |
| CN117683116B (zh) * | 2023-10-17 | 2025-08-15 | 百世美生物技术(浙江)有限公司 | 一种重组人源弹性蛋白及其制备方法与应用 |
| CN117904149A (zh) * | 2023-10-25 | 2024-04-19 | 中国医学科学院北京协和医院 | 一种表达酪氨酸酶的mRNA及用途 |
Family Cites Families (126)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3539465A (en) | 1968-10-08 | 1970-11-10 | Ncr Co | Encapsulation of hydrophilic liquid-in-oil emulsions |
| US5993434A (en) * | 1993-04-01 | 1999-11-30 | Genetronics, Inc. | Method of treatment using electroporation mediated delivery of drugs and genes |
| US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
| US5711964A (en) | 1995-06-07 | 1998-01-27 | United States Of America | Method for the intracellular delivery of biomolecules using liposomes containing cationic lipids and vitamin D |
| US6602693B1 (en) | 1996-07-03 | 2003-08-05 | Clear Solutions Biotech, Inc. | Gene encoding hyaluronan synthase |
| CA2263705C (en) | 1996-08-19 | 2007-12-04 | Nancy Smyth-Templeton | Novel sandwich liposome complexes comprising a biologically active agent |
| US6770291B2 (en) | 1996-08-30 | 2004-08-03 | The United States Of America As Represented By The Department Of Health And Human Services | Liposome complexes for increased systemic delivery |
| TW520297B (en) | 1996-10-11 | 2003-02-11 | Sequus Pharm Inc | Fusogenic liposome composition and method |
| AU5734998A (en) | 1997-01-10 | 1998-08-03 | Life Technologies, Inc. | Embryonic stem cell serum replacement |
| US6316260B1 (en) | 1997-08-22 | 2001-11-13 | Bernina Biosystems Gmbh | Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraether lipid derivatives, and use thereof |
| WO1999014346A2 (en) | 1997-09-19 | 1999-03-25 | Sequitur, Inc. | SENSE mRNA THERAPY |
| CA2376128C (en) | 1999-06-04 | 2009-01-06 | Georgia Tech Research Corporation | Devices and methods for enhanced microneedle penetration of biological barriers |
| US20110171185A1 (en) | 1999-06-30 | 2011-07-14 | Klimanskaya Irina V | Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof |
| US20020054895A1 (en) | 1999-07-23 | 2002-05-09 | Alwyn Company, Inc. | Allantoin-containing skin cream |
| US20020064876A1 (en) * | 1999-12-28 | 2002-05-30 | Kyonggeun Yoon | Novel gene therapy methods for the treatment of skin disorders |
| US6595947B1 (en) * | 2000-05-22 | 2003-07-22 | Becton, Dickinson And Company | Topical delivery of vaccines |
| ATE384072T1 (de) | 2000-09-26 | 2008-02-15 | Idera Pharmaceuticals Inc | Modulation der immunostimulatorischen aktivität von immunostimulierenden oligonukleotidanaloga durch positionelle chemische veränderungen |
| US7189759B2 (en) | 2001-05-23 | 2007-03-13 | Medicis Pharmaceutical Corporation | Compositions for the treatment of pigmentation disorders and methods for their manufacture |
| WO2003018767A2 (en) | 2001-08-27 | 2003-03-06 | Advanced Cell Technology, Inc. | Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies |
| WO2003027277A1 (en) | 2001-09-21 | 2003-04-03 | Japan Science And Technology Corporation | Method of screening reporgramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs |
| WO2003033697A1 (en) | 2001-10-18 | 2003-04-24 | Ixion Biotechnology, Inc. | Conversion of liver stem and progenitor cells to pancreatic functional cells |
| US7276489B2 (en) | 2002-10-24 | 2007-10-02 | Idera Pharmaceuticals, Inc. | Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends |
| GB0202149D0 (en) | 2002-01-30 | 2002-03-20 | Univ Edinburgh | Pluripotency determining factors and uses thereof |
| US20030186249A1 (en) * | 2002-04-01 | 2003-10-02 | Zairen Sun | Human TARPP genes and polypeptides |
| JP3785508B2 (ja) | 2002-04-15 | 2006-06-14 | 学校法人慶應義塾 | 遺伝子治療における免疫応答を解析できる実験モデルマウス |
| US7737182B2 (en) | 2002-08-09 | 2010-06-15 | Taisho Pharmaceutical Co., Ltd. | Pharmaceuticals for xerosis |
| CN1984921B (zh) | 2003-06-03 | 2010-06-16 | Isis药物公司 | 存活蛋白表达的调节 |
| JP2005046073A (ja) * | 2003-07-29 | 2005-02-24 | National Institute Of Advanced Industrial & Technology | 修飾核酸を用いるｒｎａ転写および／または増幅方法 |
| JP2007512355A (ja) | 2003-11-21 | 2007-05-17 | アルザ コーポレイション | 開裂性のｐｅｇで表面修飾されたリポソーム−ｄｎａ複合体で媒介される遺伝子送達 |
| US7682828B2 (en) | 2003-11-26 | 2010-03-23 | Whitehead Institute For Biomedical Research | Methods for reprogramming somatic cells |
| BRPI0514778B1 (pt) | 2004-09-08 | 2018-07-10 | Wisconsin Alumni Research Foundation | Meio para cultivar células tronco embrionárias |
| DK3196296T3 (en) | 2004-09-08 | 2019-02-04 | Wisconsin Alumini Res Foundation | Cultivation of human embryonic stem cells |
| WO2007014275A2 (en) | 2005-07-26 | 2007-02-01 | Sangamo Biosciences, Inc. | Targeted integration and expression of exogenous nucleic acid sequences |
| US8323666B2 (en) | 2005-08-01 | 2012-12-04 | Allergan, Inc. | Botulinum toxin compositions |
| HUE043492T2 (hu) | 2005-08-23 | 2019-08-28 | Univ Pennsylvania | Módosított nukleozidokat tartalmazó RNS és eljárások az alkalmazására |
| US9012219B2 (en) | 2005-08-23 | 2015-04-21 | The Trustees Of The University Of Pennsylvania | RNA preparations comprising purified modified RNA for reprogramming cells |
| US8476070B2 (en) | 2005-08-29 | 2013-07-02 | Technion Research & Development Foundation Limited | Media for culturing stem cells |
| CN101864392B (zh) | 2005-12-13 | 2016-03-23 | 国立大学法人京都大学 | 核重新编程因子 |
| US8129187B2 (en) | 2005-12-13 | 2012-03-06 | Kyoto University | Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2 |
| US8278104B2 (en) | 2005-12-13 | 2012-10-02 | Kyoto University | Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2 |
| JP2009520714A (ja) | 2005-12-22 | 2009-05-28 | ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー | 低オクタノエート型ヒトアルブミン |
| DE102006051516A1 (de) * | 2006-10-31 | 2008-05-08 | Curevac Gmbh | (Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins |
| GB0623635D0 (en) | 2006-11-27 | 2007-01-03 | Stem Cell Sciences Uk Ltd | Pluripotent cell growth media |
| WO2008073856A2 (en) | 2006-12-08 | 2008-06-19 | Massachusetts Institute Of Technology | Delivery of nanoparticles and/or agents to cells |
| CN101200758A (zh) | 2006-12-15 | 2008-06-18 | 华中科技大学 | 一种检测col7a1基因突变的方法及其用途 |
| US10829733B2 (en) | 2007-01-04 | 2020-11-10 | Biolamina Ab | Composition and method for enabling proliferation of pluripotent human stem cells |
| US8859229B2 (en) | 2007-02-02 | 2014-10-14 | Yale University | Transient transfection with RNA |
| US9249423B2 (en) | 2007-02-02 | 2016-02-02 | Yale University | Method of de-differentiating and re-differentiating somatic cells using RNA |
| EP3399025B1 (en) | 2007-03-23 | 2025-05-07 | Wisconsin Alumni Research Foundation | Somatic cell reprogramming |
| EP2626416A3 (en) | 2007-04-07 | 2013-12-18 | The Whitehead Institute for Biomedical Research | Reprogramming of somatic cells |
| WO2009046739A1 (en) * | 2007-10-09 | 2009-04-16 | Curevac Gmbh | Composition for treating prostate cancer (pca) |
| JP5558097B2 (ja) | 2007-12-10 | 2014-07-23 | 国立大学法人京都大学 | 効率的な核初期化方法 |
| EP2072618A1 (en) | 2007-12-14 | 2009-06-24 | Johannes Gutenberg-Universität Mainz | Use of RNA for reprogramming somatic cells |
| JP5951254B2 (ja) | 2008-03-17 | 2016-07-13 | ザ スクリプス リサーチ インスティテュート | 人工多能性幹細胞を作製するための化学的手法と遺伝的手法の組み合わせ法 |
| US20110045001A1 (en) | 2008-03-28 | 2011-02-24 | Biontex Laboratories Gmbh | Transfection results of non-viral gene delivery systems by influencing of the innate immune system |
| WO2009127230A1 (en) | 2008-04-16 | 2009-10-22 | Curevac Gmbh | MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION |
| CA2726990C (en) | 2008-06-04 | 2020-09-08 | Cellular Dynamics International, Inc. | Methods for the production of ips cells using extra-chromosomal vectors |
| WO2009147400A1 (en) | 2008-06-05 | 2009-12-10 | Iti Scotland Limited | Stem cell culture media and methods |
| WO2010008486A2 (en) | 2008-06-24 | 2010-01-21 | Parkinsons Institute | Pluripotent cell lines and methods of use thereof |
| US20100184033A1 (en) | 2008-07-16 | 2010-07-22 | West Michael D | Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells obtained thereby |
| EP2151248A1 (en) | 2008-07-30 | 2010-02-10 | Johann Bauer | Improved pre-mRNA trans-splicing molecule (RTM) molecules and their uses |
| WO2010022194A2 (en) | 2008-08-20 | 2010-02-25 | Virxsys Corporation | Compositions and methods for generation of pluripotent stem cells |
| CN102239249A (zh) | 2008-10-24 | 2011-11-09 | 威斯康星校友研究基金会 | 通过非病毒重编程获得的多潜能干细胞 |
| EP2881461A1 (en) | 2008-11-21 | 2015-06-10 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Reprogramming cells toward a pluripotent state |
| US20110239315A1 (en) | 2009-01-12 | 2011-09-29 | Ulla Bonas | Modular dna-binding domains and methods of use |
| EP2206723A1 (en) | 2009-01-12 | 2010-07-14 | Bonas, Ulla | Modular DNA-binding domains |
| US20100209404A1 (en) | 2009-02-10 | 2010-08-19 | University Of Dayton | Enhanced method for producing stem-like cells from somatic cells |
| US10894944B2 (en) | 2009-04-10 | 2021-01-19 | Monash University | Cell culture media |
| US10837020B2 (en) | 2009-04-22 | 2020-11-17 | Massachusetts Institute Of Technology | Innate immune suppression enables repeated delivery of long RNA molecules |
| WO2010123501A1 (en) | 2009-04-22 | 2010-10-28 | Massachusetts Institute Of Technology | Innate immune suppression enables repeated delivery of long rna molecules |
| ES2849181T3 (es) | 2009-04-22 | 2021-08-16 | Viacyte Inc | Composiciones celulares derivadas de células reprogramadas desdiferenciadas |
| CA2759181A1 (en) * | 2009-04-22 | 2010-10-28 | Massachusetts Institute Of Technology | Innate immune suppression enables repeated delivery of long rna molecules |
| EP2251437B1 (en) | 2009-05-13 | 2013-12-04 | Hannelore Breitenbach-Koller | Method for identifying compounds that control the translational activity of ribosomal proteins in differential mRNA expression |
| US8496941B2 (en) | 2009-06-03 | 2013-07-30 | National Institute Of Advanced Industrial Science And Technology | Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same |
| JP5944311B2 (ja) * | 2009-06-16 | 2016-07-05 | クルナ・インコーポレーテッド | コラーゲン遺伝子に対する天然アンチセンス転写物の抑制によるコラーゲン遺伝子関連疾患の治療 |
| EP3165234B1 (de) | 2009-07-31 | 2019-04-03 | ethris GmbH | Rna mit einer kombination aus unmodifizierten und modifizierten nucleotiden zur proteinexpression |
| JP5898086B2 (ja) | 2009-11-04 | 2016-04-06 | セルラー ダイナミクス インターナショナル， インコーポレイテッド | 化学物質を用いるエピソームリプログラミング |
| KR20120107088A (ko) | 2009-11-11 | 2012-09-28 | 샌포드-번햄 메디칼 리서치 인스티튜트 | ⅰＰＳ 세포들의 생산 및 조절 방법 및 그들의 조성물들 |
| KR101878502B1 (ko) | 2009-12-07 | 2018-07-13 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 세포 리프로그래밍을 위한 정제된 변형 ｒｎａ를 포함하는 ｒｎａ 제제 |
| US20130189741A1 (en) | 2009-12-07 | 2013-07-25 | Cellscript, Inc. | Compositions and methods for reprogramming mammalian cells |
| NO2510096T3 (enExample) | 2009-12-10 | 2015-03-21 | ||
| US8557972B2 (en) | 2009-12-21 | 2013-10-15 | University Of Washington Through Its Center For Commercialization | Compositions and methods for transfection of RNA and controlled stabilization of transfected RNA |
| CA2788635A1 (en) | 2010-02-01 | 2011-08-04 | The Board Of Trustees Of The Leland Stanford Junior University | Enhanced efficiency of induced pluripotent stem cell generation |
| US20140194482A1 (en) | 2010-02-02 | 2014-07-10 | Scioderm, Inc. | Compositions and methods of treatment of inflammatory skin conditions using allantoin |
| WO2011110886A1 (en) | 2010-03-09 | 2011-09-15 | Biolamina Ab | Composition and method for enabling proliferation of pluripotent human stem cells |
| EP3072961A1 (en) | 2010-04-16 | 2016-09-28 | Children's Medical Center Corporation | Sustained polypeptide expression from synthetic, modified rnas and uses thereof |
| WO2011140397A2 (en) | 2010-05-05 | 2011-11-10 | The Regents Of The University Of California Office Of The President | Stem cell defined media for xeno-free and feeder free conditions and uses thereof |
| EP2569424A1 (en) | 2010-05-12 | 2013-03-20 | Cellectis | Meganuclease variants cleaving a dna target sequence from the dystrophin gene and uses thereof |
| US8048675B1 (en) | 2010-05-12 | 2011-11-01 | Ipierian, Inc. | Integration-free human induced pluripotent stem cells from blood |
| EP3156062A1 (en) | 2010-05-17 | 2017-04-19 | Sangamo BioSciences, Inc. | Novel dna-binding proteins and uses thereof |
| EP2392208B1 (en) | 2010-06-07 | 2016-05-04 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Fusion proteins comprising a DNA-binding domain of a Tal effector protein and a non-specific cleavage domain of a restriction nuclease and their use |
| CN103180434A (zh) | 2010-08-05 | 2013-06-26 | 威斯康星校友研究基金会 | 用于人多能细胞培养的简化基础培养基 |
| CA2807552A1 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| JP5794588B2 (ja) | 2010-09-14 | 2015-10-14 | 国立大学法人京都大学 | 効率的な人工多能性幹細胞の樹立方法 |
| ES3005233T3 (en) | 2010-10-01 | 2025-03-14 | Modernatx Inc | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| WO2012048213A1 (en) | 2010-10-08 | 2012-04-12 | Regents Of The University Of Minnesota | A method to increase gene targeting frequency |
| EP2635678A4 (en) | 2010-11-04 | 2014-04-23 | Univ Kyoto | METHOD FOR EFFICIENT MANUFACTURE OF INDUCED PLURIPOTENTER STEM CELLS |
| AU2012225497A1 (en) | 2011-03-07 | 2013-10-24 | Massachusetts Institute Of Technology | Methods for transfecting cells with nucleic acids |
| JP2014511687A (ja) | 2011-03-31 | 2014-05-19 | モデルナ セラピューティクス インコーポレイテッド | 工学操作された核酸の送達および製剤 |
| WO2012131090A1 (en) * | 2011-03-31 | 2012-10-04 | Galderma Research & Development | Method for treatment of xeroderma pigmentosum |
| JP2014511694A (ja) | 2011-04-03 | 2014-05-19 | ザ ジェネラル ホスピタル コーポレーション ドゥーイング ビジネス アズ マサチューセッツ ジェネラル ホスピタル | 修飾型ｒｎａ（ｍｏｄ−ｒｎａ）を使用する効率的なインビボタンパク質発現 |
| WO2012174224A2 (en) * | 2011-06-17 | 2012-12-20 | Calando Pharmaceuticals, Inc. | Methods for administering nucleic acid-based therapeutics |
| WO2012176015A1 (en) * | 2011-06-24 | 2012-12-27 | Leo Pharma A/S | Methods for treating uv-damaged skin and scc tumors and for removing tattoos with topical ingenol mebutate |
| US9862926B2 (en) | 2011-06-27 | 2018-01-09 | Cellscript, Llc. | Inhibition of innate immune response |
| WO2013009825A1 (en) * | 2011-07-11 | 2013-01-17 | Cellular Dynamics International, Inc. | Methods for cell reprogramming and genome engineering |
| AU2012289916B2 (en) | 2011-08-03 | 2017-08-03 | Phoenix Tissue Repair, Inc. | Collagen 7 and related methods |
| EP2763701B1 (en) | 2011-10-03 | 2018-12-19 | Moderna Therapeutics, Inc. | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| ES2867054T3 (es) | 2011-10-11 | 2021-10-20 | Inst Nat Sante Rech Med | Tratamiento de salto de exones para epidermólisis ampollosa distrófica |
| JP2013086009A (ja) | 2011-10-17 | 2013-05-13 | Yamamoto Co Ltd | 自動精米装置 |
| US8497124B2 (en) | 2011-12-05 | 2013-07-30 | Factor Bioscience Inc. | Methods and products for reprogramming cells to a less differentiated state |
| RU2691027C2 (ru) | 2011-12-05 | 2019-06-07 | Фэктор Байосайенс Инк. | Способы и препараты для трансфекции клеток |
| JP2015501844A (ja) | 2011-12-16 | 2015-01-19 | モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | 修飾ヌクレオシド、ヌクレオチドおよび核酸組成物 |
| CN104968354A (zh) | 2011-12-21 | 2015-10-07 | 现代治疗公司 | 增加器官或器官外植体的活力或寿命的方法 |
| EP4721752A2 (en) | 2011-12-30 | 2026-04-08 | Cellscript, Llc | Herstellung und verwendung von in vitro-synthetisierter ssrna zur einführung in säugetierzellen zur induktion einer biologischen oder biochemischen wirkung |
| WO2013151663A1 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of membrane proteins |
| KR20150045935A (ko) | 2012-04-24 | 2015-04-29 | 더 브리검 앤드 우먼즈 하스피털, 인크. | 다능성 세포를 다시 생성하는 방법 |
| US10155929B2 (en) | 2012-05-13 | 2018-12-18 | Allele Biotechnology & Pharmaceuticals, Inc. | Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA |
| DK2850179T3 (da) | 2012-05-13 | 2019-06-17 | Allele Biotechnology & Pharmaceuticals Inc | Feeder-cellefri afledning af human-inducerede pluripotente stamceller med syntetisk messenger-rna |
| US10119150B2 (en) | 2012-05-13 | 2018-11-06 | Allele Biotechnology & Pharmaceuticals, Inc. | Feeder-free Derivation of human-induced pluripotent stem cells with synthetic messenger RNA |
| WO2014015314A1 (en) | 2012-07-19 | 2014-01-23 | University Of Southern California | Recombinant c7 and methods of use |
| KR101979746B1 (ko) * | 2012-09-13 | 2019-05-17 | (주)아모레퍼시픽 | 전기 천공 장치 |
| IL239317B (en) * | 2012-12-12 | 2022-07-01 | Broad Inst Inc | Providing, engineering and optimizing systems, methods and compositions for sequence manipulation and therapeutic applications |
| PT2959005T (pt) | 2013-02-22 | 2021-12-30 | Univ Leland Stanford Junior | Utilização médica relacionada com extensão de telómero |
| US9393257B2 (en) * | 2013-03-01 | 2016-07-19 | Regents Of The University Of Minnesota | TALEN-based gene correction |
| SG11201601939VA (en) * | 2013-09-16 | 2016-04-28 | Agency Science Tech & Res | Method |
| CN105940110A (zh) | 2014-01-31 | 2016-09-14 | 菲克特生物科学股份有限公司 | 用于核酸产生和递送的方法和产品 |
-
2015
- 2015-01-30 CN CN201580006437.9A patent/CN105940110A/zh active Pending
- 2015-01-30 US US14/761,461 patent/US9770489B2/en active Active
- 2015-01-30 KR KR1020247036521A patent/KR20240162163A/ko active Pending
- 2015-01-30 EP EP20161924.4A patent/EP3690056B1/en active Active
- 2015-01-30 KR KR1020167019564A patent/KR102415811B1/ko active Active
- 2015-01-30 RU RU2016131251A patent/RU2714404C2/ru active
- 2015-01-30 DK DK20161924.4T patent/DK3690056T5/da active
- 2015-01-30 BR BR112016017736A patent/BR112016017736A2/pt not_active IP Right Cessation
- 2015-01-30 RU RU2020104969A patent/RU2020104969A/ru unknown
- 2015-01-30 EP EP22216417.0A patent/EP4249036A3/en not_active Withdrawn
- 2015-01-30 ES ES15743915T patent/ES2787198T3/es active Active
- 2015-01-30 ES ES20161924T patent/ES2939542T3/es active Active
- 2015-01-30 WO PCT/US2015/013949 patent/WO2015117021A1/en not_active Ceased
- 2015-01-30 AU AU2015210769A patent/AU2015210769B2/en active Active
- 2015-01-30 KR KR1020227022074A patent/KR102726294B1/ko active Active
- 2015-01-30 JP JP2016533700A patent/JP2017510542A/ja active Pending
- 2015-01-30 FI FIEP20161924.4T patent/FI3690056T3/fi active
- 2015-01-30 EP EP15743915.9A patent/EP3099801B1/en active Active
- 2015-01-30 CA CA2937036A patent/CA2937036A1/en active Pending
- 2015-01-30 MX MX2016009771A patent/MX372651B/es active IP Right Grant
-
2016
- 2016-07-27 MX MX2020006065A patent/MX2020006065A/es unknown
-
2017
- 2017-08-16 US US15/678,491 patent/US10124042B2/en active Active
-
2018
- 2018-06-12 US US16/006,461 patent/US20180271951A1/en not_active Abandoned
-
2019
- 2019-03-07 AU AU2019201576A patent/AU2019201576A1/en not_active Abandoned
- 2019-09-06 US US16/562,494 patent/US12201675B2/en active Active
-
2020
- 2020-07-30 JP JP2020128881A patent/JP7235702B2/ja active Active
-
2022
- 2022-02-17 AU AU2022201056A patent/AU2022201056A1/en not_active Abandoned
-
2023
- 2023-02-24 JP JP2023026873A patent/JP2023075165A/ja active Pending
-
2024
- 2024-09-03 JP JP2024151104A patent/JP2025003953A/ja active Pending
- 2024-12-13 US US18/980,218 patent/US20250195622A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3690056T3 (fi) | Menetelmiä ja tuotteita nukleiinihapon valmistamiseksi ja viemiseksi | |
| ES2962434T3 (es) | Procedimientos y composiciones para editar ARN | |
| JP7698828B2 (ja) | Ｒｎａを編集する方法および組成物 | |
| JP7093728B2 (ja) | 化学的に修飾されたガイドｒｎａを使用する高特異性ゲノム編集 | |
| RU2016123086A (ru) | Способы и композиции для лечения болезни хантингтона | |
| JP2023075165A5 (enExample) | ||
| FI3604532T3 (fi) | Uusia crispr-entsyymejä ja järjestelmiä | |
| JP6808617B2 (ja) | 連続性を維持した転位 | |
| CN109072235B (zh) | 通过核递送crispr/cas9追踪并操纵细胞rna | |
| WO2023241669A1 (zh) | CRISPR-Cas效应子蛋白、其基因编辑系统及应用 | |
| BR112019019655A2 (pt) | editores de nucleobase que compreendem proteínas de ligação a dna programáveis por ácido nucleico | |
| KR20160050068A (ko) | 스위칭가능한 ｃａｓ９ 뉴클레아제 및 그의 용도 | |
| JP2016512691A5 (enExample) | ||
| CN107794272A (zh) | 一种高特异性的crispr基因组编辑体系 | |
| RU2018101710A (ru) | Мутации фермента crispr, уменьшающие нецелевые эффекты | |
| JP2013530689A5 (enExample) | ||
| JP2014527401A5 (enExample) | ||
| CN117431234A (zh) | 用于基因组编辑分子的细胞内递送的肽和纳米颗粒 | |
| US20190085315A1 (en) | Methods for enhancing the efficiency of gene editing | |
| US11939574B2 (en) | Ribosomal RNA origami and methods preparing thereof | |
| JP2015128433A5 (enExample) | ||
| WO2019117714A8 (en) | Methods for preparing nucleic acid molecules for sequencing | |
| JP2013507934A5 (enExample) | ||
| CN114729359A (zh) | 程序性dna驱动的自组装rna水凝胶 | |
| JP2016086711A5 (enExample) |